In patients with T2DM, decreasing baseline RBP4 quartiles were associated with progressively higher all-cause mortality risk: HR = 1.87 for Q 3, 1.49 for Q 2, and 4.01 for Q 1, compared to Q 4 (p for trend = 0.004). This evidence concerns the gene RBP4 and type 2 diabetes mellitus.